Recent studies have reported that ML algorithms have been utilized to identify lymph node metastases, scoring KI67 positivity in breast cancer, scoring tumor-infiltrating lymphocytes in melanoma, and Gleason grading in prostate cancer (83). This evidence concerns the gene MKI67 and breast carcinoma.